ASPE ASPEN NEUROSCIENCE INC
FollowCommon Stock, par value $0.0001 per share (common), issuer CIK 2124080
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- ORBIMED ADVISORS LLC(group ORBIMED ADVISORS LLC)
3,589,132 shares, 12.3% in a 13D as of 2026-11-02,0000947871-26-000996
Accepted , ingested - ARCH Venture Fund X, L.P.(group ARCH Venture Partners XII, LLC)
3,754,922 shares, 12.9% in a 13D as of 2026-11-02,0001193125-26-454047
Accepted , ingested - Frazier Life Sciences X, L.P. (group Frazier Life Sciences Public Fund, L.P.)
1,674,321 shares, 5.8% in a 13G as of 2026-11-02,0001231919-26-001553
Accepted , ingested - FMR LLC(group FMR LLC)
3,250,000 shares, 11.2% in a 13G as of 2026-10-30,0000315066-26-002950
Accepted , ingested - GILEAD SCIENCES, INC.(group GILEAD SCIENCES, INC.)
2,879,996 shares, 9.9% in a 13G as of 2026-10-30,0001123292-26-001496
Accepted , ingested - Qatar Investment Authority
1,933,330 shares, 6.7% in a 13G as of 2026-10-30,0001441449-26-000011
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Hasnain Faheemdirector, officer (Executive Chair) | 2026-11-05 | +321,672 A | $0 | Form 4 |
Events
ARCH Venture Fund X, L.P. and 12 other reporting persons reported 3,754,922 ASPE shares, 12.9% of the class, as of 2026-11-02, in a 13D filed 2026-11-09. 0001193125-26-454047
Accepted , ingestedHasnain Faheem acquired 321,672 ASPE shares on 2026-11-05, Form 4 filed 2026-11-09. 0001193125-26-453834
Accepted , ingestedFrazier Life Sciences X, L.P. and 4 other reporting persons reported 1,674,321 ASPE shares, 5.8% of the class, as of 2026-11-02, in a 13G filed 2026-11-09. 0001231919-26-001553
Accepted , ingestedORBIMED ADVISORS LLC and 1 other reporting person reported 3,589,132 ASPE shares, 12.3% of the class, as of 2026-11-02, in a 13D filed 2026-11-06. 0000947871-26-000996
Accepted , ingestedGILEAD SCIENCES, INC. reported 2,879,996 ASPE shares, 9.9% of the class, as of 2026-10-30, in a 13G filed 2026-11-06. 0001123292-26-001496
Accepted , ingestedFMR LLC and 1 other reporting person reported 3,250,000 ASPE shares, 11.2% of the class, as of 2026-10-30, in a 13G filed 2026-11-06. 0000315066-26-002950
Accepted , ingestedQatar Investment Authority reported 1,933,330 ASPE shares, 6.7% of the class, as of 2026-10-30, in a 13G filed 2026-11-03. 0001441449-26-000011
Accepted , ingested